Abstract Details

Title Objective and Subjective Efficacy of Natalizumab on Disability and Fatigue in Relapsing Remitting (RR) and Relapsing Progressive (RP) Multiple Sclerosis (MS) over a 2 Year Period

Topic MS and Related Diseases

Presentation(s) (-)

Poster/Presentation
Number 148

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Doumos Loannis	No disclosure on file
Vassiliki Kotsi	No disclosure on file
Elissaios Karageorgiou, MD, PhD, FAAN (Neurological Institute of Athens)	Dr. Karageorgiou has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Myrtelle. The institution of Dr. Karageorgiou has received research support from European Union.
	No disclosure on file
Dimitrios Tzortzis	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
Helen Papageorgiou, MD	No disclosure on file
Sofia Tsiara, MD	No disclosure on file

��ɫ��

��ɫ��

Abstract Details

��ɫ����

��ɫ����

��ɫ��

��ɫ��